ABSTRACT
Purpose: The COVID-19 pandemic has brought about several changes in the regular life of consumers. One such field is eGrocery, where a surge in online grocery orders were seen when the nation was on lockdown. The purpose of this study is to study the impact of COVID-19 on eGrocery and to find a relation between consumer's demographic characteristics and the satisfaction level of ordering groceries online. Design/methodology/approach: The author has conducted primary research by doing a survey online. One hundred sixty diverse responses were received, which were further analyzed using SPSS software and visually represented through Tableau. Findings: The paper finds that demographic variables, especially gender and age, affect consumers' behavior while making online grocery purchases. Findings also reveal there is a difference among the five recognized attributes, Convenient Delivery Slots, Better Deals/Discounts, Cash free transactions, Return policy, and social distancing, before and during the lockdown. We also find that respondents leaned towards brick and mortar stores for their grocery shopping before the outbreak and more towards eGrocery platforms such as BigBasket (45%), Zomato (25%) during the pandemic. Originality/value: The main contribution of this paper is to analyze the behavior of consumers during the pandemic of 2020. Currently, not many relevant papers are there for reference. This paper can serve as a reference for the students who opt for a similar topic, want to study, and write on the COVID-19 outbreak.
ABSTRACT
SESSION TITLE: Management of COVID-19-Induced Complications SESSION TYPE: Rapid Fire Case Reports PRESENTED ON: 10/19/2022 12:45 pm - 1:45 pm INTRODUCTION: Evans syndrome (ES) is a rare autoimmune disorder characterized by the combination of two or more cytopenias with an incidence of 0.8-3.7%.Here we present a case of COVID-19 pneumonia complicated by the development of ES. CASE PRESENTATION: A 75-year-old female with the past medical history of 50 pack-year smoking, recent asymptomatic COVID-19 Pneumonia 2 week ago came to the emergency room (ER) with shortness of breath. Her vitals and physical exam were unremarkable. Labs were significant for leukocytosis of 11.66 and D-dimer of 3.32. CT pulmonary angiogram showed bilateral pulmonary embolism along with a COVID-19 pattern of pneumonia. She was started on heparin drip and was eventually discharged on Warfarin with Prednisone taper. After 3 weeks, she presented to the ER with worsening shortness of breath. She was found to have platelet count of 4k and Hb of 6.6 gm%(compared to 370k and 13.1 gm% on last discharge) and was started on transfusions which could not be completed due to development of mid-transfusion fever. She received Dexamethasone and IVIG. All forms of active bleeding were ruled out by bronchoscopy, CT scans and EGD. Flow cytometry was negative for ADAMTS13 ruling out thrombotic thrombocytopenic purpura. Bone marrow biopsy was unremarkable. She was positive for IgG warm agglutinin hemolytic anemia. She was discharged on long-term Prednisone taper. In the clinic she was given intermittent IVIG and Romiplostim to improve her counts. Due to multiple failed attempts to wean her off steroids, she was started on Rituximab with an excellent response of platelets increment to 450k and Hb to 8.5 gm%. Rituximab will be given for a total of 8 weeks. DISCUSSION: ES is considered to be caused by immune system dysregulation. ES in COVID-19 is a diagnostic dilemma as the thrombocytopenia is usually misdiagnosed as COVID-19 sequelae and leads to delay in diagnosis. The treatment of ES is usually with steroids 1 mg/kg/day but they only provide short term improvement. Rituximab, plasma exchange, IVIG, and splenectomy are second-line treatments for relapsing/refractory ES. Our patient had an acceptable response to steroids but it was transient,demonstrating the limited role of steroids in the long term and was eventually treated successfully with Rituximab. A review of limited published cases of ES caused by COVID-19 suggests that diagnosis, treatments, and prognosis are usually individualized according to patient characteristics, presenting symptoms, physician preference, and disease complications. CONCLUSIONS: ES is a very rare syndrome although it requires prompt treatment. It is important to be mindful about immunological causes when a COVID-19 patient presents with cytopenia, as delay in treatment can cause poor outcomes. Reference #1: Turgutkaya A, Bolaman AZ, Yavaşoğlu Í. COVID-19-associated Evans syndrome: A case report and review of the literature. Transfus Apher Sci. 2021 Dec 7:103339. doi: 10.1016/j.transci.2021.103339. Epub ahead of print. PMID: 34896007;PMCID: PMC8655821. DISCLOSURES: No relevant relationships by Nitesh Jain No relevant relationships by Kashyap Kela No relevant relationships by Princy Shah No relevant relationships by namita sharma No relevant relationships by AMIT SHARMA
ABSTRACT
Today's world of 21st-century business is said to be a VUCA (Volatility-Uncertainty-Complexity-Ambiguity) world. VUCA describes the fast pace of change in the business environment. It has largely been led by the disruption brought about by technology-led human resources departments within organisations to revise strategy approaches and methods to face these emerging challenges. Research studies show that more than two-thirds of the companies in the world belong to family businesses. In the family business, the owners and HR should see what is going on in the business environment and update the situation. As most family businesses have family members in key positions, the tricky issues faced by family businesses are mostly about handling family and non-family members and creating effective HR policies. The COVID-19 pandemic in 2019 and 2020 has disrupted their business in unexpected ways. This chapter explores different HR practices adopted by the family business and suggests effective HR practices and procedures to meet the multiple challenges in the family business. The chapter also analyses the strategies of HR practices followed by some top family business firms worldwide. The chapter is formed as a meta-synthesis. It provides more qualitative inputs related to recent challenges and effective HR practices adopted in the technologically competitive era and during the COVID-19 pandemic period. © 2022 World Scientific Publishing Co. Pte. Ltd.
ABSTRACT
As the world grapples with the COVID-19 pandemic and major populations are getting vaccinated, increasing realization processes healthcare industry needs to be augmented. It includes managing supply chains, healthcare records, and patient care. With a scarcity of time and resources, adaptation of blockchain technology will help mitigate the pressures on existing infrastructure. A blockchain distributed ledger helps to exchange health information securely without complex intermediation of trust with secure access. The organizations and persons in the blockchain network can verify and authorize the data, thus protecting patient identity, privacy, medical information system, and reducing transaction costs. The chapter examines managing and protecting electronic medical records and personal health records data using blockchain. It also analyses issues in healthcare, blockchain implementation, and its uses in the COVID-19 pandemic. The authors put forward the idea that even after the world is free of the Coronavirus, there will be pressures on the healthcare industry and Blockchain technology is the way to alleviate this pressure. © 2022 Elsevier Inc. All rights reserved.
ABSTRACT
Coronavirus disease 2019 (COVID-19) is a global pandemic where several comorbidities have been shown to have a significant effect on mortality. Patients with diabetes mellitus (DM) have a higher mortality rate than non-DM patients if they get COVID-19. Recent studies have indicated that patients with a history of diabetes can increase the risk of severe acute respiratory syndrome coronavirus 2 infection. Additionally, patients without any history of diabetes can acquire new-onset DM when infected with COVID-19. Thus, there is a need to explore the bidirectional link between these two conditions, confirming the vicious loop between “DM/COVID-19”. This narrative review presents (1) the bidirectional association between the DM and COVID-19, (2) the manifestations of the DM/COVID-19 loop leading to cardiovascular disease, (3) an understanding of primary and secondary factors that influence mortality due to the DM/COVID-19 loop, (4) the role of vitamin-D in DM patients during COVID-19, and finally, (5) the monitoring tools for tracking atherosclerosis burden in DM patients during COVID-19 and “COVID-triggered DM” patients. We conclude that the bidirectional nature of DM/COVID-19 causes acceleration towards cardiovascular events. Due to this alarming condition, early monitoring of atherosclerotic burden is required in “Diabetes patients during COVID-19” or “new-onset Diabetes triggered by COVID-19 in non-Diabetes patients”.
ABSTRACT
As the world grapples with the Covid-19 pandemic and major populations are getting vaccinated, increasing realisation processes healthcare industry needs to be augmented. It includes managing supply chains, healthcare records, and patient care. With a scarcity of time and resources, adaptation of blockchain technology will help mitigate the pressures on existing infrastructure. A blockchain distributed ledger helps to exchange health information securely without complex intermediation of trust with secure access. The organisations and persons in the blockchain network can verify and authorise the data, thus protecting patient identity, privacy, medical information system, and reducing transaction costs. The paper examines managing and protecting electronic medical records and personal health records data using blockchain. It also analyses issues in healthcare, blockchain implementation, and its uses in the Covid-19 pandemic. © 2022, The Author(s), under exclusive license to Springer Nature Switzerland AG.
ABSTRACT
In June 13, 2012, coronavirus infection started in Saudi Arabia. Coronavirus was first recorded as being responsible for common flu in 1960. During 2002-2003, coronavirus was studied as a simple, non-fatal virus. The major types of coronavirus are severe acute respiratory syndrome (SARS), Coronavirinae, Arterivirdae, Roniviridae, Coronaviridae. Recent outbreak took place in China which causes severe acute respiratory syndrome (SARS) that came from Wuhan seafood Market. This paper illustrates the brief outline of recent epidemic of novel Coronavirus named 2019-nCoV in China. Preventative measures taken in China as well as in India are also discussed in this draft.